NEW
YORK, May 26, 2023 /PRNewswire/ -- Jakubowitz
Law announces that a merger investigation has commenced on behalf
of shareholders of NRx Pharmaceuticals Inc. (f/k/a Big Rock
Partners Acquisition Corp.) ("NRXP" or the "Company") (NASDAQ:
NRXP) who purchased stock prior to May 24,
2021 and still hold such stock.
This investigation concerns the fairness of NRXP's 2021 de-SPAC
merger. Shortly after the NRXP 2021 de-SPAC merger closed, NRXP
stock began spiraling downwards.
To be contacted by a member of our team, fill out the
form:
https://claimyourloss.com/mergeracquisition/nrx-pharmaceuticals-merger-investigation-information-request-form/
The NRXP de-SPAC merger investigation concerns whether this
transaction unfairly harmed stockholders and whether all material
facts were properly disclosed to stockholders.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (628) 895-0423
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/nrxp-shareholder-alert-jakubowitz-law-notifies-shareholders-of-an-investigation-into-the-fairness-of-nrx-pharmaceuticals-incs-de-spac-merger-301830890.html
SOURCE Jakubowitz Law